Grant: Engage Grants Program
University of Waterloo
$25,000.00
Development of affordable at-line surface plasmon resonance technology for critical quality attribute assessment of complex biologics
EF 2014-15
Résumé
Surface plasmon resonance (SPR) is a technique that uses optical measurement of the refractive index of a metal surface to detect binding of an analyte to receptors on this surface. A typical sensor is based off a glass support surface coated with a gold film. Receptors are then bound to the gold film. Light shone on the underside of the gold film is reflected at a critical angle and received by a sensor. Molecules binding to the surface affect the critical angle and therefore the concentration of binding analyte can be measured. As part of the network on the Production of Single Glycoform Monoclonal Antibodies (MabNet), Professor Aucoin is looking at developing processes that influence the glycosylation pattern of monoclonal antibodies produced in animal cell culture. The glycosylation pattern is known to influence dramatically the ability of an antibody to bind to different targets. He is also developing processes for the production of viruses and virus-like particles that can be used in vaccines. Both of these types of complex biologics need to be characterized through their ability to bind to other molecules. Helping develop an affordable SPR device such as the one being produced by Nicoya Lifesciences, a Waterloo-based start-up company, will certainly prove to be an invaluable process analytical tool (PAT) which will help in the monitoring of a critical quality attribute (CQA) of important therapeutic biomolecules (namely therapeutic antibodies, viruses and virus-like particles).
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
471460-2014
Name nom
Aucoin, Marc
Department département
Chemical Engineering
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2014
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
1802
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Biochemical engineering
Research subject fr
Génie biochimique
Partie
1
Nb partie
1
Application title
Development of affordable at-line surface plasmon resonance technology for critical quality attribute assessment of complex biologics
Keyword
NSERC
Application summary
Surface plasmon resonance (SPR) is a technique that uses optical measurement of the refractive index of a metal surface to detect binding of an analyte to receptors on this surface. A typical sensor is based off a glass support surface coated with a gold film. Receptors are then bound to the gold film. Light shone on the underside of the gold film is reflected at a critical angle and received by a sensor. Molecules binding to the surface affect the critical angle and therefore the concentration of binding analyte can be measured. As part of the network on the Production of Single Glycoform Monoclonal Antibodies (MabNet), Professor Aucoin is looking at developing processes that influence the glycosylation pattern of monoclonal antibodies produced in animal cell culture. The glycosylation pattern is known to influence dramatically the ability of an antibody to bind to different targets. He is also developing processes for the production of viruses and virus-like particles that can be used in vaccines. Both of these types of complex biologics need to be characterized through their ability to bind to other molecules. Helping develop an affordable SPR device such as the one being produced by Nicoya Lifesciences, a Waterloo-based start-up company, will certainly prove to be an invaluable process analytical tool (PAT) which will help in the monitoring of a critical quality attribute (CQA) of important therapeutic biomolecules (namely therapeutic antibodies, viruses and virus-like particles).